6-112109466-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001105206.3(LAMA4):​c.5443G>A​(p.Val1815Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0024 in 1,614,012 control chromosomes in the GnomAD database, including 122 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1815V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0027 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 111 hom. )

Consequence

LAMA4
NM_001105206.3 missense

Scores

6
5
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 6.93

Publications

13 publications found
Variant links:
Genes affected
LAMA4 (HGNC:6484): (laminin subunit alpha 4) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]
LAMA4 Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1JJ
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004704684).
BP6
Variant 6-112109466-C-T is Benign according to our data. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112109466-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 44408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0619 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA4NM_001105206.3 linkc.5443G>A p.Val1815Ile missense_variant Exon 39 of 39 ENST00000230538.12 NP_001098676.2 Q16363A0A0A0MQS9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA4ENST00000230538.12 linkc.5443G>A p.Val1815Ile missense_variant Exon 39 of 39 1 NM_001105206.3 ENSP00000230538.7 A0A0A0MQS9

Frequencies

GnomAD3 genomes
AF:
0.00271
AC:
412
AN:
152174
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0672
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00521
AC:
1307
AN:
251092
AF XY:
0.00479
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0637
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000291
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00237
AC:
3457
AN:
1461720
Hom.:
111
Cov.:
31
AF XY:
0.00233
AC XY:
1692
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33474
American (AMR)
AF:
0.000112
AC:
5
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0712
AC:
2827
AN:
39694
South Asian (SAS)
AF:
0.00353
AC:
304
AN:
86238
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53402
Middle Eastern (MID)
AF:
0.000697
AC:
4
AN:
5736
European-Non Finnish (NFE)
AF:
0.0000953
AC:
106
AN:
1111962
Other (OTH)
AF:
0.00333
AC:
201
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
186
372
558
744
930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00273
AC:
415
AN:
152292
Hom.:
11
Cov.:
32
AF XY:
0.00299
AC XY:
223
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41564
American (AMR)
AF:
0.000458
AC:
7
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0678
AC:
351
AN:
5178
South Asian (SAS)
AF:
0.00580
AC:
28
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68024
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00197
Hom.:
25
Bravo
AF:
0.00321
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00523
AC:
635
Asia WGS
AF:
0.0320
AC:
112
AN:
3476
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

May 01, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val1808Ile in Exon 39 of LAMA4: This variant is not expected to have clinical si gnificance because it has been identified in 12.8% (11/86) of chromosomes from a population in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP; rs3 734292). -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 09, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1JJ Benign:5
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 03, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Aug 09, 2017
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26406308, 31180159) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.030
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.024
T;T;T;T
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.83
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;.;.;D
MetaRNN
Benign
0.0047
T;T;T;T
MetaSVM
Uncertain
0.15
D
PhyloP100
6.9
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.91
N;N;N;N
REVEL
Uncertain
0.33
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D
Vest4
0.80
MVP
0.77
MPC
0.52
ClinPred
0.048
T
GERP RS
6.2
gMVP
0.57
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3734292; hg19: chr6-112430669; COSMIC: COSV57897940; API